Caribou Biosciences Inc
NASDAQ:CRBU
Caribou Biosciences Inc
NASDAQ:CRBU
Price:
1.78
USD
-6.81%
Market Closed
Market Cap:
$166.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Caribou Biosciences Inc
NASDAQ:CRBU
|
US |
|
R
|
Rich Sport PCL
SET:RSP
|
TH |
|
T
|
Taiwan Business Bank Ltd
TWSE:2834
|
TW |
|
Koninklijke Ahold Delhaize NV
OTC:ADRNY
|
NL |
|
G
|
Great Boulder Resources Ltd
ASX:GBR
|
AU |
|
Keppel DC REIT
SGX:AJBU
|
SG |
|
Qianhe Condiment and Food Co Ltd
SSE:603027
|
CN |
|
T
|
Thanulux PCL
SET:TNL
|
TH |
|
C
|
CareMax Inc
NASDAQ:CMAX
|
US |
|
I
|
INC SA
WSE:INC
|
PL |
|
O
|
Orion Office Reit Inc
NYSE:ONL
|
US |
|
Compania de Distribucion Integral Logista Holdings SA
MAD:LOG
|
ES |
|
Weebit Nano Ltd
ASX:WBT
|
AU |
|
Steel & Tube Holdings Ltd
NZX:STU
|
NZ |
|
M
|
M-Tron Industries Inc
AMEX:MPTI
|
US |
|
R
|
Renco Holdings Group Ltd
HKEX:2323
|
HK |
|
P
|
Parkson Holdings Bhd
KLSE:PARKSON
|
MY |
|
HDFC Bank Ltd
NYSE:HDB
|
IN |
|
X
|
Xinjiang Yilite Industry Co Ltd
SSE:600197
|
CN |
|
P
|
Precious Shipping PCL
SET:PSL
|
TH |
|
WiSA Technologies Inc
NASDAQ:WISA
|
US |
|
PP Properti Tbk PT
IDX:PPRO
|
ID |
Multiples-Based Value
The Multiples-Based Value of one
CRBU
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 1.78 USD,
Caribou Biosciences Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CRBU Multiples-Based Value
LOCKED
Multiples Across Competitors
CRBU Competitors Multiples
Caribou Biosciences Inc Competitors
Caribou Biosciences Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Caribou Biosciences Inc
NASDAQ:CRBU
|
169.4m USD | 15.2 | -1.1 | -0.2 | -0.2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
370.2B USD | 6.1 | 88.4 | 14.7 | 20.4 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
355.4B USD | 109.4 | -1 708.3 | 15 870 | -1 791.9 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188B USD | 5.1 | 24.4 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.6B USD | 5.7 | 19.6 | 12.3 | 15.1 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.2B USD | 9.2 | 27.8 | 20.9 | 21.8 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78B USD | 5.4 | 17.3 | 12.7 | 14.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
69.6B AUD | 3.2 | 35.1 | 11.5 | 14.5 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
